Bacterioscan Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Bacterioscan's estimated annual revenue is currently $5M per year.(i)
  • Bacterioscan's estimated revenue per employee is $251,000

Employee Data

  • Bacterioscan has 20 Employees.(i)
  • Bacterioscan grew their employee count by -5% last year.

Bacterioscan's People

NameTitleEmail/Phone
1
Chief Operating OfficerReveal Email/Phone
2
CEOReveal Email/Phone
3
VP Research and BiologyReveal Email/Phone
4
VP EngineeringReveal Email/Phone
5
Director, Regulatory & Quality AssuranceReveal Email/Phone
6
Manager Operations and Supply ChainReveal Email/Phone
7
Regional Sales DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$24.6M98-4%N/AN/A
#2
$36.6M1462%N/AN/A
#3
$8.5M343%N/AN/A
#4
$2.8M1110%N/AN/A
#5
$75M142-6%N/AN/A
#6
$17.8M7113%N/AN/A
#7
$35M1900%$80MN/A
#8
$12.6M509%N/AN/A
#9
$28.1M112-20%N/AN/A
#10
$9.8M393%N/AN/A
Add Company

What Is Bacterioscan?

BacterioScan, Inc. is a medical device company dedicated to changing the way infectious disease is diagnosed and treated. We are driven by a fundamental desire to ensure the successful use of antibiotics. Our innovative instrumentation platform is built on the rapid detection and antibiotic susceptibility testing of infectious pathogens. We produce reliable, precision instrumentation that rapidly detects and measures microorganism growth in liquid specimens, determines if it is resistant to a range of antibiotics and provides clinicians with patient-specific guidance on the fastest and most cost-effective antibiotic treatment. Our technologies help to improve the quality of antibiotic therapy, reduce excess or inappropriate use of antibiotics and deter antibiotic resistance. The real-time bacteria detection and antimicrobial resistance data we collect and aggregate through our network can be used to inform clinical decision-making and the medical community's response to emerging threats related to infectious disease and antibiotic resistance worldwide.

keywords:N/A

N/A

Total Funding

20

Number of Employees

$5M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Bacterioscan News

2022-04-17 - Chippendales lobbies up- POLITICO

Forest Hill Consulting: Bacterioscan Inc Franklin Square Group, LLC: Magic Leap, Inc. Freemyer & Associates P.C.: Alton Coal Development

2022-04-17 - Podesta reregisters as a foreign agent- POLITICO

Forest Hill Consulting: Bacterioscan Inc Holland & Knight LLP: Illinois Tool Works, Inc. Jwf Consulting LLC: Mha

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2M20-5%N/A
#2
$3.5M20-17%N/A
#3
$2M205%N/A
#4
$3.4M2131%$5M
#5
$4M21-16%N/A